Loading provider…
Loading provider…
Neurological Surgery Physician in Sun City, AZ
NPI: 1326038506Primary Practice Location
Banner Alzheimer's Institute
10515 W Santa Fe Dr, Sun City, AZ
Primary Employer
Banner Alzheimer's Institute
bannerhealth.com
HQ Phone
Get MD PHD Alireza's Phone Numberphone_androidMobile
Get MD PHD Alireza's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 96138Administration of psychological or neuropsychological test by technician, first 30 minutes | 19 | 38 |
| 2 | G2212Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 19 | 157 |
| 3 | 96116Neurobehavioral status examination, interpretation, and report by psychologist or physician per hour | 18 | 37 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 16 | 36 |
Baseline Characteristics from Evoke and Evoke+: Two Phase 3 Randomized Placebo-controlled Trials of Oral Semaglutide in Patients with Early Alzheimer's Disease (P11-9.013).
Authors: Howard Feldman
Publication Date: 2025-02-20
Authors: Jönsson, Linus, Ivkovic, Milana, Atri, Alireza, Handels, Ron, Gustavsson, Anders, Hahn-Pedersen, Julie Hviid, León, Teresa, Lilja, Mathias, Gundgaard, Jens, Raket, Lars Lau
Journal: Alzheimers Res Ther
Publication Date: 2024-02-29
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: LY3202626
Lead Sponsor: H. Lundbeck A/S
Collaborators: Otsuka Pharmaceutical Co., Ltd.
Intervention / Treatment: DRUG: Placebo, DRUG: Idalopirdine